AMPK stimulation increases LCFA but not glucose clearance in cardiac muscle in vivo

American Journal of Physiology - Endocrinology and Metabolism

Volumn 287, Issue 5 50-5, 2004, Pages

  Shearer, Jane ^a   Fueger, Patrick T ^a   Rottman, Jeffrey N ^b   Bracy, Deanna P ^a   Martin, Paul H ^b   Wasserman, David H ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

AMP activated protein kinase; Carbohydrate; Heart; Interaction; Lipid; Long chain fatty acid; Substrate

Indexed keywords

15 (4 IODOPHENYL) 3 METHYLPENTADECANOIC ACID I 125; 5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; ACETYL COENZYME A CARBOXYLASE; BENZENE DERIVATIVE; DECANOIC ACID DERIVATIVE; DEOXYGLUCOSE; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INTRALIPID; LONG CHAIN FATTY ACID; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; SERINE; SODIUM CHLORIDE; THREONINE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CLEARANCE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INDUCTION; ENZYME PHOSPHORYLATION; GLUCOSE UTILIZATION; HEART MUSCLE; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

AMINOIMIDAZOLE CARBOXAMIDE; ANIMALS; ENZYME ACTIVATION; ENZYME INHIBITORS; FAT EMULSIONS, INTRAVENOUS; FATTY ACIDS; GLUCOSE; HYPOGLYCEMIC AGENTS; MALE; MULTIENZYME COMPLEXES; MYOCARDIUM; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROTEIN-SERINE-THREONINE KINASES; RATS; RATS, SPRAGUE-DAWLEY; RIBONUCLEOTIDES;

EID: 6044272946     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00125.2004     Document Type: Article

References (47)

1. Ally A and Park G. Rapid determination of creatine, phosphocreatine, purine bases and nucleotides (ATP, ADP, AMP, GTP, GDP) in heart biopsies by gradient ion-pair reversed-phase liquid chromatography. J Chromatogr 575: 19-27, 1992.
2. Arnal JF, Warin L, and Michel JB. Determinants of aortic cyclic guanosine monophosphate in hypertension induced by chronic inhibition of nitric oxide synthase. J Clin Invest 90: 647-652, 1992.
3. Balent B, Goswami G, Goodloe G, Rogatsky E, Rauta O, Nezami R, Mints L, Angeletti R, and Stein D. Acute elevation of NEFA causes hyperinsulinemia without effect on insulin secretion rate in healthy human subjects. Ann NY Acad Sci 967: 535-543, 2002.
4. Barnes K, Ingram JC, Porras OH, Barros LF, Hudson ER, Fryer LG, Foufelle F, Carling D, Hardie DG, and Baldwin SA. Activation of GLUT1 by metabolic and osmotic stress: potential involvement of AMP-activated protein kinase (AMPK). J Cell Sci 115: 2433-2442, 2002.
5. Baron AD and Clark MG. Role of blood flow in the regulation of muscle glucose uptake. Annu Rev Nutr 17: 487-499, 1997.
6. Bernstein R, Ochoa F, Xu X, Forfia P, Shen W, Thompson C, and Hintze T. Function and production of nitric oxide in the coronary circulation of the conscious dog during exercise. Circ Res 79: 840-848, 1996.
7. Chen ZP, McConell GK, Michell BJ, Snow RJ, Canny BJ, and Kemp BE. AMPK signaling in contracting human skeletal muscle: acetyl-CoA carboxylase and NO synthase phosphorylation. Am J Physiol Endocrinol Metab 279: E1202-E1206, 2000.
8. Chen ZP, Mitchelhill KI, Michell BJ, Stapleton D, Rodriguez-Crespo I, Witters LA, Power DA, Ortiz de Montellano PR, and Kemp BE. AMP-activated protein kinase phosphorylation of endothelial NO synthase. FEBS Lett 443: 285-289, 1999.
9. Coburn CT, Knapp FF Jr, Febbraio M, Beets AL, Silverstein RL, and Abumrad NA. Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout mice. J Biol Chem 275: 32523-32529, 2000.
10. Cullen MJ, Hollingworth S, and Marshall MW. A comparative study of the transverse tubular system of the rat extensor digitorum longus and soleus muscles. J Anat 138: 297-308, 1984.
11. Dombrowski L, Roy D, Marcotte B, and Marette A. A new procedure for the isolation of plasma membranes, T-tubules, and internal membranes from skeletal muscle. Am J Physiol Endocrinol Metab 270: E667-E676, 1996.
12. Dyck DJ, Putman CT, Heigenhauser GJ, Hultman E, and Spriet LL. Regulation of fat-carbohydrate interaction in skeletal muscle during intense aerobic cycling. Am J Physiol Endocrinol Metab 265: E852-E859, 1993.
13. Fisher JS, Gao J, Han DH, Holloszy JO, and Nolte LA. Activation of AMP kinase enhances sensitivity of muscle glucose transport to insulin. Am J Physiol Endocrinol Metab 282: E18-E23, 2002.
14. Fueger PT, Bracy DP, Malabanan CM, Pencek RR, and Wasserman DH. Distributed control of glucose uptake by working muscles of conscious mice: roles of transport and phosphorylation. Am J Physiol Endocrinol Metab 286: E77-E84, 2004.
15. 3H]deoxy-D-glucose pharmacokinetics in the rat. Am J Physiol Endocrinol Metab 255: E806-E811, 1988.
16. Halseth AE, Bracy DP, and Wasserman DH. Limitations to basal and insulin-stimulated skeletal muscle glucose uptake in the high-fat-fed rat. Am J Physiol Endocrinol Metab 279: E1064-E1071, 2000.
17. Hargreaves M, Kiens B, and Richter EA. Effect of increased plasma free fatty acid concentrations on muscle metabolism in exercising men. J Appl Physiol 70: 194-201, 1991.
18. Higaki Y, Hirshman MF, Fujii N, and Goodyear LJ. Nitric oxide increases glucose uptake through a mechanism that is distinct from the insulin and contraction pathways in rat skeletal muscle. Diabetes 50: 241-247, 2001.
19. Kaikita K, Fogo AB, Ma L, Schoenhard JA, Brown NJ, and Vaughan DE. Plasminogen activator inhibitor-1 deficiency prevents hypertension and vascular fibrosis in response to long-term nitric oxide synthase inhibition. Circulation 104: 839-844, 2001.
20. Kraegen EW, James DE, Jenkins AB, and Chisholm DJ. Dose-response curves for in vivo insulin sensitivity in individual tissues in rats. Am J Physiol Endocrinol Metab 248: E353-E362, 1985.
21. Kudo N, Gillespie JG, Kung L, Witters LA, Schulz R, Clanachan AS, and Lopaschuk GD. Characterization of 5′ AMP-activated protein kinase activity in the heart and its role in inhibiting acetyl-CoA carboxylase during reperfusion following ischemia. Biochim Biophys Acta 1301: 67-75, 1996.
22. Kurth-Kraczek E, Hirshman M, Goodyear L, and Winder W. 5′ AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle. Diabetes 48: 1667-1671, 1999.
23. Lemieux K, Konrad D, Klip A, and Marette A. The AMP-activated protein kinase activator AICAR does not induce GLUT4 translocation to transverse tubules but stimulates glucose uptake and p38 mitogen-activated protein kinases α and β in skeletal muscle. FASEB J 17: 1658-1665, 2003.
24. Longnus SL, Wambolt RB, Parsons HL, Brownsey RW, and Allard MF. 5-Aminoimidazole-4-carboxamide 1-β-D-ribofuranoside (AICAR) stimulates myocardial glycogenolysis by allosteric mechanisms. Am J Physiol Regul Integr Comp Physiol 284: R936-R944, 2003.
25. Lopaschuk GD. Metabolic abnormalities in the diabetic heart. Heart Fail Rev 7: 149-159, 2002.
26. Lopaschuk GD, Belke DD, Gamble J, Itoi T, and Schonekess BO. Regulation of fatty acid oxidation in the mammalian heart in health and disease. Biochim Biophys Acta 1213: 263-276, 1994.
27. Lopaschuk GD, Collins-Nakai RL, and Itoi T. Developmental changes in energy substrate use by the heart. Cardiovasc Res 26: 1172-1180, 1992.
28. Luiken JJ, Koonen DP, Willems J, Zorzano A, Becker C, Fischer Y, Tandon NN, Van Der Vusse GJ, Bonen A, and Glatz JF. Insulin stimulates long-chain fatty acid utilization by rat cardiac myocytes through cellular redistribution of FAT/CD36. Diabetes 51: 3113-3119, 2002.
29. Luiken JJ, Schaap FG, van Nieuwenhoven FA, van der Vusse GJ, Bonen A, and Glatz JF. Cellular fatty acid transport in heart and skeletal muscle as facilitated by proteins. Lipids 34, Suppl: S169-S175, 1999.
30. Luiken JJFP, Coort SLM, Willems J, Coumans WA, Bonen A, van der Vusse GJ, and Glatz JFC. Contraction-induced fatty acid translocase/CD36 translocation in rat cardiac myocytes is mediated through AMP-activated protein kinase signaling. Diabetes 52: 1627-1634, 2003.
31. Maki MT, Haaparanta M, Nuutila P, Oikonen V, Luotolahti M, Eskola O, and Knuuti JM. Free fatty acid uptake in the myocardium and skeletal muscle using fluorine-18-fluoro-6-thia-heptadecanoic acid. J Nucl Med 39: 1320-1327, 1998.
32. Makinde AO, Gamble J, and Lopaschuk GD. Upregulation of 5′-AMP-activated protein kinase is responsible for the increase in myocardial fatty acid oxidation rates following birth in the newborn rabbit. Circ Res 80: 482-489, 1997.
33. Makinde AO, Kantor PF, and Lopaschuk GD. Maturation of fatty acid and carbohydrate metabolism in the newborn heart. Mol Cell Biochem 188: 49-56, 1998.
34. Meszaros K, Bagby GJ, Lang CH, and Spitzer JJ. Increased uptake and phosphorylation of 2-deoxyglucose by skeletal muscles in endotoxin-treated rats. Am J Physiol Endocrinol Metab 253: E33-E39, 1987.
35. Mezaros K, Lang CH, Hargrove DM, and Spitzer JJ. Tissue glucose utilization during epinephrine-induced hyperglycemia. J Appl Physiol 67: 1770-1775, 1989.
36. Morgan CR and Lazarow AL. Immunoassay of insulin: two-antibody system. Plasma insulin of normal, subdiabetic, and diabetic rats. Am J Med Sci 257: 415-419, 1963.
37. Morrow VA, Foufelle F, Connell JM, Petrie JR, Gould GW, and Salt IP. Direct activation of AMP-activated protein kinase stimulates nitric oxide synthesis in human aortic endothelial cells. J Biol Chem 278: 31629-31639, 2003.
38. max for insulin-stimulated muscle glucose uptake in vivo. Am J Physiol Endocrinol Metab 284: E541-E548, 2003.
39. Rottman JN, Bracy D, Malabanan C, Yue Z, Clanton J, and Wasserman DH. Contrasting effects of exercise and NOS inhibition on tissue-specific fatty acid and glucose uptake in mice. Am J Physiol Endocrinol Metab 283: E116-E123, 2002.
40. Russell RR III, Bergeron R, Shulman GI, and Young LH. Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR. Am J Physiol Heart Circ Physiol 277: H643-H649, 1999.
41. Shearer J, Fueger PT, Vorndick B, Bracy DP, Rottman JN, Clanton JA, and Wasserman DH. AMP kinase-induced skeletal muscle glucose but not long-chain fatty acid uptake is dependent on nitric oxide. Diabetes 53: 1429-1435, 2004.
42. Stanley WC, Lopaschuk GD, and McCormack JG. Regulation of energy substrate metabolism in the diabetic heart. Cardiovasc Res 34: 25-33, 1997.
43. Ventura-Clapier R, Garnier A, and Veksler V. Energy metabolism in heart failure. J Physiol 555: 1-13, 2004.
44. 14C]deoxyglucose into glycogen in heart and skeletal muscle in vivo: implications for the quantitation of tissue glucose uptake. Diabetes 46: 1106-1110, 1997.
45. Winder WW and Hardie DG. Inactivation of acetyl-CoA carboxylase and activation of AMP-activated protein kinase in muscle during exercise. Am J Physiol Endocrinol Metab 270: E299-E304, 1996.
46. Wynants J and Van Belle H. Single-run high-performance liquid chromatography of nucleotides, nucleosides, and major purine bases and its application to different tissue extracts. Anal Biochem 144: 258-266, 1985.
47. Zatz R and Baylis C. Chronic nitric oxide inhibition model six years on. Hypertension 32: 958-964, 1998.